New Clues: Protecting Nerve Coating and Axons in MS

Credibility

Interest

Share:2 min read

Key Takeaway

Oligodendrocytes need a specific transporter (MCT2) to keep the myelin coat and nearby nerve fibers healthy, and boosting metabolism may help when MCT2 is low in progressive MS.

What They Found

Researchers found that mature myelin-making cells called oligodendrocytes use a protein called MCT2 to move small energy fuels into cells; MCT2 levels are lower in progressive MS. Removing MCT2 in a mouse model did not kill the oligodendrocytes, but it changed how they make fats needed for myelin, so the myelin began to fail like a worn-out insulating jacket. This change also increased inflammation, and nearby nerve fibers showed signs of stress and damage, such as turning on a protective enzyme called lactate dehydrogenase A. Mice with MCT2 removed had worse myelin maintenance under mild inflammation compared with control mice that only had a little inflammation. Feeding the mice a ketogenic diet (a high-fat, low-carb diet that shifts body fuel toward fats and related molecules) eased some of the nerve damage, suggesting metabolism can be changed to help protect myelin and axons.

Who Should Care and Why

People with MS and their caregivers should care because this study points to a specific metabolic problem (low MCT2) that can make myelin and nerve fibers break down, especially in progressive MS. Think of MCT2 like a delivery door that brings in fuel for the cell’s factory; when the door is closed, the factory can’t make the materials (fats) that keep the insulation (myelin) intact. Healthcare teams may use these findings to think about adding metabolic strategies, like diet or targeted therapies, alongside current MS treatments to protect nerve insulation. Caregivers should know that changes in energy use in the brain—not just immune attacks—can affect symptoms and long-term nerve health. Patients with progressive MS might benefit most from research and therapies that aim to support cell metabolism and myelin maintenance.

Important Considerations

This study used mice and lab methods, so results may not work the same in humans right away, and more clinical research is needed before changing treatments. The ketogenic diet helped in mice, but that does not mean every person with MS should start this diet without medical advice, because diets can have side effects and interact with medications. The exact causes of MCT2 loss in progressive MS are not fully known, so treatments would need careful testing to confirm safety and benefit.

AI-generated summary — for informational purposes only, not medical advice

Categories:

Early Research MS Progression MS Genetics

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Nature communications often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News